Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors

Aptamer‐Engineered Natural Killer Cells for Cell‐Specific Adaptive Immunotherapy

(2019) Shuanghui Yang et al.   Small

Pioneering Adoptive Immunotherapy with Natural Killer Cells

(2019) Bartosz Grzywacz   STEM CELLS AND DEVELOPMENT

Bispecific Aptamer Induced Artificial Protein-Pairing: A Strategy for Selective Inhibition of Receptor Function

(2019) Liping Wang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Artificial Engineered Natural Killer Cells Combined with Antiheat Endurance as a Powerful Strategy for Enhancing Photothermal‐Immunotherapy Efficiency of Solid Tumors

(2019) Da Zhang et al.   Small

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

(2018) Ye Li et al.   Cell Stem Cell

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering

(2018) May Daher et al.   CURRENT OPINION IN IMMUNOLOGY

Nongenetic Approach for Imaging Protein Dimerization by Aptamer Recognition and Proximity-Induced DNA Assembly

(2018) Hong Liang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Aptamer-based targeted therapy

(2018) Guizhi Zhu et al.   ADVANCED DRUG DELIVERY REVIEWS

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

(2018) Joy Hsu et al.   JOURNAL OF CLINICAL INVESTIGATION

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

(2018) Pascale André et al.   CELL

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

(2017) E Liu et al.   LEUKEMIA

A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect

(2017) Bo-Tsang Huang et al.   Molecular Therapy-Nucleic Acids

Functional nucleic acid-based hydrogels for bioanalytical and biomedical applications

(2016) Juan Li et al.   CHEMICAL SOCIETY REVIEWS

Aptamers as targeted therapeutics: current potential and challenges

(2016) Jiehua Zhou et al.   NATURE REVIEWS DRUG DISCOVERY

A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects

(2016) Wei-Yun Lai et al.   Molecular Therapy-Nucleic Acids

Natural Killer Cell Adoptive Transfer Therapy

(2015) Zachary B. Davis et al.   CANCER JOURNAL

Advantages and applications of CAR-expressing natural killer cells

(2015) Wolfgang Glienke et al.   Frontiers in Pharmacology

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity

(2015) David L. Hermanson et al.   Frontiers in Immunology

Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications

(2015) Mattias Carlsten et al.   Frontiers in Immunology

Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape

(2014) A. C. Anderson   Cancer Immunology Research

DNA Aptamer-Mediated Cell Targeting

(2012) Xiangling Xiong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer

(2012) Ling Meng et al.   PLoS One

Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers

(2011) Fernando Pastor et al.   MOLECULAR THERAPY

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

(2010) D. M. Benson et al.   BLOOD

Development of DNA aptamers using Cell-SELEX

(2010) Kwame Sefah et al.   Nature Protocols

Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach

(2009) Xiaohong Fang et al.   ACCOUNTS OF CHEMICAL RESEARCH

Adaptive immune features of natural killer cells

(2009) Joseph C. Sun et al.   NATURE